Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEPMag simplified magnesium sulfate regimen trial
ISRCTN13720473Phase 3Recruiting
- Sponsor
- World Health Organization
- Start
- Nov 2022
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of magnesium sulfate in preeclampsia (2 arms), sponsored by World Health Organization. Primary endpoint: Maternal eclamptic seizure. Started Nov 2022; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ISRCTN13720473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13720473.